Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Theocharides, Alexandre PA"'
Autor:
Marques‐Maggio, Ewerton, Maccio, Umberto, Marx, Alexandra, Galli, Serena, Schwab, Nathalie, Frank, Angela, Hamelin, Baptiste, Varga, Zsuzsanna, Nombela‐Arrieta, César, Mertz, Kirsten D, Theocharides, Alexandre PA, Koelzer, Viktor H
Publikováno v:
Histopathology; Oct2023, Vol. 83 Issue 4, p582-590, 9p
Autor:
Marques-Maggio, Ewerton, Maccio, Umberto, Marx, Alexandra, Galli, Serena, Schwab, Nathalie, Frank, Angela, Hamelin, Baptiste, Varga, Zsuzsanna, Nombela-Arrieta, César, Mertz, Kirsten D, Theocharides, Alexandre Pa, Koelzer, Viktor H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500989d8becf26f62458cb0c6bddb622
https://www.zora.uzh.ch/id/eprint/234183/
https://www.zora.uzh.ch/id/eprint/234183/
Autor:
Stark, Stefan G, Ficek, Joanna, Locatello, Francesco, Bonilla, Ximena, Chevrier, Stéphane, Singer, Franziska, Aebersold, Rudolf, Al-Quaddoomi, Faisal S, Albinus, Jonas, Alborelli, Ilaria, Andani, Sonali, Attinger, Per-Olof, Bacac, Marina, Baumhoer, Daniel, Beck-Schimmer, Beatrice, Beerenwinkel, Niko, Beisel, Christian, Bernasconi, Lara, Bertolini, Anne, Bodenmiller, Bernd, Casanova, Ruben, Chicherova, Natalia, D'Costa, Maya, Danenberg, Esther, Davidson, Natalie, gan, Monica-Andreea Dră, Dummer, Reinhard, Engler, Stefanie, Erkens, Martin, Eschbach, Katja, Esposito, Cinzia, Fedier, André, Ferreira, Pedro, Frei, Anja L, Frey, Bruno, Goetze, Sandra, Grob, Linda, Gut, Gabriele, Günther, Detlef, Haberecker, Martina, Haeuptle, Pirmin, Heinzelmann-Schwarz, Viola, Herter, Sylvia, Holtackers, Rene, Huesser, Tamara, Irmisch, Anja, Jacob, Francis, Jacobs, Andrea, Jaeger, Tim M, Jahn, Katharina, James, Alva R, Jermann, Philip M, Kahles, André, Kahraman, Abdullah, Koelzer, Viktor H, Kuebler, Werner, Kuipers, Jack, Kunze, Christian P, Kurzeder, Christian, Lehmann, Kjong-Van, Levesque, Mitchell, Lugert, Sebastian, Maass, Gerd, Manz, Markus, Markolin, Philipp, Mena, Julien, Menzel, Ulrike, Metzler, Julian M, Miglino, Nicola, Milani, Emanuela S, Moch, Holger, Muenst, Simone, Murri, Riccardo, Ng, Charlotte KY, Nicolet, Stefan, Nowak, Marta, Pedrioli, Patrick GA, Pelkmans, Lucas, Piscuoglio, Salvatore, Prummer, Michael, Ritter, Mathilde, Rommel, Christian, Rosano-González, María L, Rätsch, Gunnar, Santacroce, Natascha, Castillo, Jacobo Sarabia del, Schlenker, Ramona, Schwalie, Petra C, Schwan, Severin, Schär, Tobias, Senti, Gabriela, Sivapatham, Sujana, Snijder, Berend, Sobottka, Bettina, Sreedharan, Vipin T, Stark, Stefan, Stekhoven, Daniel J, Theocharides, Alexandre PA, Thomas, Tinu M, Tolnay, Markus, Tosevski, Vinko, Toussaint, Nora C, Tuncel, Mustafa A, Tusup, Marina, Drogen, Audrey Van, Vetter, Marcus, Vlajnic, Tatjana, Weber, Sandra, Weber, Walter P, Wegmann, Rebekka, Weller, Michael, Wendt, Fabian, Wey, Norbert, Wicki, Andreas, Wollscheid, Bernd, Yu, Shuqing, Ziegler, Johanna, Zimmermann, Marc, Zoche, Martin, Zuend, Gregor
Publikováno v:
Bioinformatics
Bioinformatics, 36 (S2)
Bioinformatics, 36 (S2)
Motivation: Recent technological advances have led to an increase in the production and availability of single-cell data. The ability to integrate a set of multi-technology measurements would allow the identification of biologically or clinically mea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4925abb7a5d25d3c8452a01e981de017
https://doi.org/10.5167/uzh-198481
https://doi.org/10.5167/uzh-198481
Autor:
Drexler, Beatrice, Passweg, Jakob R, Tzankov, Alexandar, Bigler, Martin, Theocharides, Alexandre Pa, Cantoni, Nathan, Keller, Peter, Stussi, Georg, Ruefer, Axel, Benz, Rudolf, Favre, Geneviève, Lundberg, Pontus, Nienhold, Ronny, Fuhrer, Andrea, Biaggi, Christine, Manz, Markus G, Bargetzi, Mario, Mendez-Ferrer, Simon, Skoda, Radek C, Swiss Group For Clinical Cancer Research (SAKK)
The β-3 sympathomimetic agonist BRL37344 restored nestin-positive cells within the stem cell niche, and thereby normalized blood counts and improved myelofibrosis in a mouse model of JAK2-V617F-positive myeloproliferative neoplasms. We therefore tes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6bfc51f08037808c29b3c5e68deef3b
https://www.repository.cam.ac.uk/handle/1810/286886
https://www.repository.cam.ac.uk/handle/1810/286886
Autor:
Drexler, Beatrice *, Passweg, Jakob, Bigler, Martin *, Theocharides, Alexandre PA *, Cantoni, Nathan, Keller, Peter, Stuessi, Georg *, Rüfer, Axel *, Benz, Rudolf A., Favre, Geneviève, Tzankov, Alexandar *, Lundberg, Pontus *, Fuhrer, Andrea *, Biaggi, Christine *, Manz, Markus G, Bargetzi, Mario, Mendez-Ferrer, Simon, Skoda, Radek C.
Publikováno v:
In Blood 2 December 2016 128(22):3108-3108
Publikováno v:
In Blood 2 December 2016 128(22):2206-2206
Autor:
Theocharides, Alexandre PA, Jin, Liqing, Poeppl, Armando G, Prasolava, Tatiana K, Gan, Olga I, Minden, Mark D, Danska, Jayne S, Dick, John E, Wang, Jean CY
Publikováno v:
Blood; November 2009, Vol. 114 Issue: 22 p476-476, 1p
Autor:
Losa M; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland., Emmenegger M; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland., De Rossi P; Department of Quantitative Biomedicine, University of Zürich, Zurich, Switzerland., Schürch PM; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Serdiuk T; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland., Pengo N; Mabylon AG, Schlieren, Zurich, Switzerland., Capron D; Mabylon AG, Schlieren, Zurich, Switzerland., Bieli D; Mabylon AG, Schlieren, Zurich, Switzerland., Bargenda N; Department of Quantitative Biomedicine, University of Zürich, Zurich, Switzerland., Rupp NJ; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Carta MC; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland., Frontzek KJ; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland., Lysenko V; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Reimann RR; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland., Schwarz P; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland., Nuvolone M; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland.; Amyloidosis Research and Treatment Center, Fondazione Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, University of Pavia, Pavia, Italy., Westermark GT; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden., Nilsson KPR; Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden., Polymenidou M; Department of Quantitative Biomedicine, University of Zürich, Zurich, Switzerland., Theocharides AP; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Hornemann S; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland., Picotti P; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland., Aguzzi A; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland. adriano.aguzzi@usz.ch.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2024 Jul 30. Date of Electronic Publication: 2024 Jul 30.
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells.
Autor:
Mueller J; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Schimmer RR; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Koch C; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Schneiter F; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Fullin J; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Lysenko V; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Pellegrino C; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Klemm N; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Russkamp N; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Myburgh R; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Volta L; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Theocharides AP; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Kurppa KJ; Institute of Biomedicine and Medicity Research Laboratories, University of Turku, Turku, Finland., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Schroeder T; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Manz MG; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland., Boettcher S; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland. steffen.boettcher@usz.ch.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2024 Mar; Vol. 16 (3), pp. 445-474. Date of Electronic Publication: 2024 Feb 14.
Autor:
Drexler B; Division of Hematology, University Hospital Basel and University of Basel, Switzerland., Passweg JR; Division of Hematology, University Hospital Basel and University of Basel, Switzerland jakob.passweg@usb.ch., Tzankov A; Institute of Pathology, University Hospital Basel and University of Basel, Switzerland., Bigler M; Swiss Group for Clinical Cancer Research, Bern, Switzerland., Theocharides AP; Hematology and Oncology, University Hospital Zurich and University of Zurich, Switzerland., Cantoni N; Oncology, Hematology & Transfusion Medicine, Kantonsspital Aarau AG, Switzerland., Keller P; University Clinic of Hematology and Central Hematology Laboratory, University Hospital Bern, Switzerland., Stussi G; Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Ruefer A; Departement Medizin, Luzerner Kantonsspital, Switzerland., Benz R; Kantonsspital Muensterlingen, Switzerland., Favre G; Cantonal Hospital Liestal, Switzerland., Lundberg P; Division of Hematology, University Hospital Basel and University of Basel, Switzerland., Nienhold R; Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland., Fuhrer A; Swiss Group for Clinical Cancer Research, Bern, Switzerland., Biaggi C; Swiss Group for Clinical Cancer Research, Bern, Switzerland., Manz MG; Hematology and Oncology, University Hospital Zurich and University of Zurich, Switzerland., Bargetzi M; Oncology, Hematology & Transfusion Medicine, Kantonsspital Aarau AG, Switzerland., Mendez-Ferrer S; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge, and National Health Service Blood and Transplant, Cambridge, UK., Skoda RC; Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland radek.skoda@unibas.ch.
Publikováno v:
Haematologica [Haematologica] 2019 Apr; Vol. 104 (4), pp. 710-716. Date of Electronic Publication: 2018 Nov 08.